(Stock Photo)
AI-powered health monitoring is evolving from automating routine observations to helping care providers identify emerging risks, interpret subtle changes and prioritize clinical intervention.
Artificial intelligence (AI) is opening a new chapter in elder care and healthcare, where its value extends beyond reducing staff workloads. By analyzing physiological data, identifying deviations from normal patterns and estimating the risk of clinical deterioration, AI systems could help care providers intervene earlier and make better-informed decisions.
Three solutions from Panasonic, Respiree and Sanome illustrate how this trend is developing across long-term care and hospital settings.
Panasonic: Recognizing Subtle Changes Before They Become Obvious
In October 2026, Panasonic Holdings began field testing its Predictive-Sign Solution with the Japanese social welfare organization (社会福祉法人ユーアイ二十一と) to evaluate its usefulness in care facilities.
The technology combines sensor-data analysis with generative AI. It examines heart rate, respiratory rate, movement, sleep and bed occupancy, comparing each resident's patterns with their usual condition. A second AI component generates reports explaining detected changes, supporting data and points for caregivers to observe.
In a retrospective evaluation involving approximately 2,000 older people, Panasonic reported an 89.4% recall rate for health changes documented in historical care records and a 10.5% false-alarm rate under its evaluation method. The company is now testing how the system performs in actual care operations. These results do not establish clinical diagnostic accuracy or prove that the system can predict future emergencies.
The broader significance lies in its potential to turn continuous monitoring data into actionable observations, helping staff recognize changes that might otherwise go unnoticed. Panasonic also aims to support compatibility with different monitoring systems, potentially allowing facilities to build on existing infrastructure.
Source: Panasonic official announcement
Respiree: Predicting Acute Deterioration in Hospitals
Singapore-based health technology company Respiree takes a more clinically focused approach. Its 1Bio AI-Acute software received approval from Singapore's Health Sciences Authority in December 2025 as a Class B software medical device.
The system analyzes routinely recorded vital signs, including pulse rate, respiratory rate, oxygen saturation and systolic blood pressure, to generate a risk score indicating the likelihood of acute deterioration. Clinicians can use the score and its trends to determine whether closer monitoring or further assessment may be needed.
Rather than simply flagging individual abnormal readings, AI-based risk scoring aims to improve the precision of early-warning alerts and reduce unnecessary notifications. This could help hospital teams direct attention toward patients who require closer observation.
Source: Respiree announcement
Sanome MEMORI: Turning Clinical Data Into Early Warnings
UK health technology company Sanome has developed MEMORI, an AI-powered clinical decision-support system that analyzes patient information from electronic health records to help clinicians identify emerging health risks, including infection and deterioration.
The system consolidates information such as vital signs, laboratory results, medications and clinical notes, helping clinicians recognize patterns that may be difficult to identify when data is spread across multiple records. It also presents explanations and suggested next steps within clinical workflows.
MEMORI illustrates how AI can move beyond monitoring individual measurements to interpreting a patient's broader clinical picture. For healthcare operators, this could support more timely assessments and better prioritization of clinical resources, particularly when teams manage large numbers of patients.
Source: Sanome MEMORI
From Monitoring to More Proactive Care
Together, these developments highlight three complementary capabilities: recognizing subtle changes in residents, estimating the likelihood of acute deterioration, and interpreting complex clinical information to support earlier intervention.
For nursing home operators, hospital groups and long-term care providers, adopting AI should begin with a clear clinical or operational objective—not simply a goal of reducing staff workload. Facilities should evaluate how effectively a solution identifies meaningful risks, integrates with existing systems, manages false alarms and supports timely staff responses.
Pilot projects should measure outcomes beyond labor savings, including time to intervention, avoidable hospital transfers, staff workload and implementation costs. Operators should also distinguish between technologies undergoing field testing and products with established clinical deployment.
Ultimately, AI's value will depend not simply on how quickly it processes information, but on whether its insights help care teams recognize risks earlier, allocate attention more effectively and make better-informed decisions while keeping human care and clinical judgment at the center.
🚀 Connect with Global Leaders in Aging & Care Innovation!
Sourcingcares links international partners in aging care, long-term care, and health technology, fostering collaboration and driving solutions for a changing world. Our initiatives include Cares Expo Taipei, where the future of elder care takes shape!
🔗 Follow us for insights & opportunities:
📌 Facebook: sourcingcares
📌 LinkedIn: sourcingcares
📍 Explore more at Cares Expo Taipei!
